CPP
ABMD

Crow Point Partners’s Abiomed Inc ABMD Stock Holding History

Crow Point Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$298K Buy
+1,783
New +$331K 0.47% 47
2018
Q3 		– Sell
-530
Closed -$219K – 167
2018
Q2 		$219K Sell
530
-49
-8% -$17.8K 0.04% 103
2018
Q1 		$168K Sell
579
-52
-8% -$13.2K 0.03% 103
2017
Q4 		$120K Buy
+631
New +$118K 0.02% 161

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Crow Point Partners's ABMD Position: Q4 2019 in Review

Crow Point Partners opened a new position in Abiomed Inc (ABMD) in Q4 2019: 1,783 shares worth $298K. The stake represents 0.47% of the portfolio and ranks #47 among its holdings. This is a return to the name: Crow Point Partners previously reported a position in ABMD as recently as Q2 2018.

Crow Point Partners first reported a position in ABMD in Q4 2017 and has held it in 4 quarters since. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Crow Point Partners held 1,783 shares of Abiomed Inc worth $298K as of Q4 2019.
  • Abiomed Inc was a new Crow Point Partners position in Q4 2019.
  • Abiomed Inc made up 0.47% of Crow Point Partners's portfolio in Q4 2019, its #47 holding.
  • Crow Point Partners first reported a position in Abiomed Inc in Q4 2017 and has held it in 4 quarters since.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.